The Enterprise Value as of December 2025 (TTM) for Gemina Laboratories Ltd. (GLABF) is 15.54M

According to Gemina Laboratories Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 15.54M. This represents a change of -65.30% compared to the average of 44.79M of the last 4 quarters.

Gemina Laboratories Ltd. (GLABF) Historical Enterprise Value (quarterly & annually)

How has GLABF Enterprise Value performed in the past?

The mean historical Enterprise Value of Gemina Laboratories Ltd. over the last ten years is 32.88M. The current 15.54M Enterprise Value has changed 4.63% with respect to the historical average. Over the past ten years (40 quarters), GLABF's Enterprise Value was at its highest in in the April 2025 quarter at 77.39M. The Enterprise Value was at its lowest in in the July 2020 quarter at 0.

Gemina Laboratories Ltd. (GLABF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Gemina Laboratories Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Gemina Laboratories Ltd. (GLABF) Average Enterprise Value

How has GLABF Enterprise Value performed in the past?

The current Enterprise Value of Gemina Laboratories Ltd. (GLABF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Gemina Laboratories Ltd. (GLABF) Enterprise Value vs. Peers

How is GLABF’s Enterprise Value compared to its peers?

Gemina Laboratories Ltd.’s Enterprise Value is greater than Quest PharmaTech Inc. (7.62M), less than Telescope Innovations Corp. (17.36M), greater than Propanc Biopharma, Inc. (10.29M), less than Cell Source, Inc. (27.11M), greater than Zenith Capital Corp. (11.15M), greater than Synairgen plc (1.06M), greater than AccuStem Sciences Limited (-31341.00), greater than Sirona Biochem Corp. (9.37M), less than PreveCeutical Medical Inc. (19.22M), less than Hemostemix Inc. (19.07M),

Build a custom stock screener for Gemina Laboratories Ltd. (GLABF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Gemina Laboratories Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Gemina Laboratories Ltd. (GLABF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Gemina Laboratories Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.